| # | Title | Journal | Year | Citations |
|---|
| 1 | Risk of venous thromboembolism in patients with COVID‐19: A systematic review and meta‐analysis | Research and Practice in Thrombosis and Haemostasis | 2020 | 366 |
| 2 | Fibrinogen and fibrin: An illustrated review | Research and Practice in Thrombosis and Haemostasis | 2019 | 151 |
| 3 | The coagulation system in host defense | Research and Practice in Thrombosis and Haemostasis | 2018 | 126 |
| 4 | Integrating platelet and coagulation activation in fibrin clot formation | Research and Practice in Thrombosis and Haemostasis | 2018 | 122 |
| 5 | Current practice patterns and patient persistence with anticoagulant treatments for cancer‐associated thrombosis | Research and Practice in Thrombosis and Haemostasis | 2017 | 109 |
| 6 | The dual role of platelet‐innate immune cell interactions in thrombo‐inflammation | Research and Practice in Thrombosis and Haemostasis | 2020 | 101 |
| 7 | Pathogenesis, prevention, and management of bleeding and thrombosis in patients with liver diseases | Research and Practice in Thrombosis and Haemostasis | 2017 | 92 |
| 8 | A proposal for staging COVID‐19 coagulopathy | Research and Practice in Thrombosis and Haemostasis | 2020 | 82 |
| 9 | Venous thromboembolism in critically Ill patients with COVID‐19: Results of a screening study for deep vein thrombosis | Research and Practice in Thrombosis and Haemostasis | 2020 | 82 |
| 10 | Safety and effectiveness of apixaban compared to warfarin in dialysis patients | Research and Practice in Thrombosis and Haemostasis | 2018 | 78 |
| 11 | Thrombotic thrombocytopenic purpura: Toward targeted therapy and precision medicine | Research and Practice in Thrombosis and Haemostasis | 2019 | 74 |
| 12 | A review of commercially available thrombin generation assays | Research and Practice in Thrombosis and Haemostasis | 2018 | 71 |
| 13 | Direct oral anticoagulants compared to low‐molecular‐weight heparin for the treatment of cancer‐associated thrombosis: Updated systematic review and meta‐analysis of randomized controlled trials | Research and Practice in Thrombosis and Haemostasis | 2020 | 69 |
| 14 | Prothrombotic changes in patients with COVID‐19 are associated with disease severity and mortality | Research and Practice in Thrombosis and Haemostasis | 2021 | 69 |
| 15 | Vaccine‐induced Immune Thrombocytopenia and Thrombosis (VITT) | Research and Practice in Thrombosis and Haemostasis | 2021 | 68 |
| 16 | Peak plasma concentration of direct oral anticoagulants in obese patients weighing over 120 kilograms: A retrospective study | Research and Practice in Thrombosis and Haemostasis | 2018 | 66 |
| 17 | Using heparin molecules to manage COVID‐2019 | Research and Practice in Thrombosis and Haemostasis | 2020 | 64 |
| 18 | Polyphosphate in thrombosis, hemostasis, and inflammation | Research and Practice in Thrombosis and Haemostasis | 2019 | 63 |
| 19 | Pulmonary embolism response teams: Purpose, evidence for efficacy, and future research directions | Research and Practice in Thrombosis and Haemostasis | 2019 | 57 |
| 20 | Heparin‐induced thrombocytopenia with thrombosis in COVID‐19 adult respiratory distress syndrome | Research and Practice in Thrombosis and Haemostasis | 2020 | 57 |
| 21 | Direct oral anticoagulants and warfarin for venous thromboembolism treatment: Trends from 2012 to 2017 | Research and Practice in Thrombosis and Haemostasis | 2019 | 54 |
| 22 | Increased risk of thrombotic events in cold agglutinin disease: A 10‐year retrospective analysis | Research and Practice in Thrombosis and Haemostasis | 2020 | 54 |
| 23 | Circulating endothelial cells as biomarker for cardiovascular diseases | Research and Practice in Thrombosis and Haemostasis | 2019 | 53 |
| 24 | Current and future burden of venous thrombosis: Not simply predictable | Research and Practice in Thrombosis and Haemostasis | 2018 | 52 |
| 25 | Measurement of tissue factor activity in extracellular vesicles from human plasma samples | Research and Practice in Thrombosis and Haemostasis | 2019 | 52 |
| 26 | Performing and interpreting individual pharmacokinetic profiles in patients with Hemophilia A or B: Rationale and general considerations | Research and Practice in Thrombosis and Haemostasis | 2018 | 50 |
| 27 | Sexism in the management of bleeding disorders | Research and Practice in Thrombosis and Haemostasis | 2021 | 50 |
| 28 | Thrombosis and coagulopathy in COVID‐19: An illustrated review | Research and Practice in Thrombosis and Haemostasis | 2020 | 49 |
| 29 | Thrombin generation measurement using the ST Genesia Thrombin Generation System in a cohort of healthy adults: Normal values and variability | Research and Practice in Thrombosis and Haemostasis | 2019 | 47 |
| 30 | Risk of thrombotic complications in influenza versus COVID‐19 hospitalized patients | Research and Practice in Thrombosis and Haemostasis | 2021 | 47 |
| 31 | Management of anticoagulation for cancer‐associated thrombosis in patients with thrombocytopenia: A systematic review | Research and Practice in Thrombosis and Haemostasis | 2018 | 47 |
| 32 | Acute infection as a trigger for incident venous thromboembolism: Results from a population‐based case‐crossover study | Research and Practice in Thrombosis and Haemostasis | 2018 | 46 |
| 33 | BAY 1213790, a fully human IgG1 antibody targeting coagulation factor XIa: First evaluation of safety, pharmacodynamics, and pharmacokinetics | Research and Practice in Thrombosis and Haemostasis | 2019 | 46 |
| 34 | Tranexamic acid evidence and controversies: An illustrated review | Research and Practice in Thrombosis and Haemostasis | 2021 | 46 |
| 35 | The impact of body weight on rivaroxaban pharmacokinetics | Research and Practice in Thrombosis and Haemostasis | 2017 | 44 |
| 36 | Emergence of institutional antithrombotic protocols for coronavirus 2019 | Research and Practice in Thrombosis and Haemostasis | 2020 | 44 |
| 37 | The coagulation system in atherothrombosis: Implications for new therapeutic strategies | Research and Practice in Thrombosis and Haemostasis | 2018 | 43 |
| 38 | 3D ultrastructural analysis of α‐granule, dense granule, mitochondria, and canalicular system arrangement in resting human platelets | Research and Practice in Thrombosis and Haemostasis | 2020 | 43 |
| 39 | Fully automated thromboelastograph TEG 6s to measure anticoagulant effects of direct oral anticoagulants in healthy male volunteers | Research and Practice in Thrombosis and Haemostasis | 2019 | 42 |
| 40 | Venous thromboembolism in a large cohort of children with acute lymphoblastic leukemia: Risk factors and effect on prognosis | Research and Practice in Thrombosis and Haemostasis | 2019 | 42 |
| 41 | Hemophilia trials in the twenty‐first century: Defining patient important outcomes | Research and Practice in Thrombosis and Haemostasis | 2019 | 42 |
| 42 | Novel aspects of antiplatelet therapy in cardiovascular disease | Research and Practice in Thrombosis and Haemostasis | 2018 | 41 |
| 43 | Potential role of platelets in COVID‐19: Implications for thrombosis | Research and Practice in Thrombosis and Haemostasis | 2020 | 41 |
| 44 | Comparison of the coagulopathies associated with COVID‐19 and sepsis | Research and Practice in Thrombosis and Haemostasis | 2021 | 41 |
| 45 | Managing thrombosis in cancer patients | Research and Practice in Thrombosis and Haemostasis | 2018 | 40 |
| 46 | What’s new in VTE risk and prevention in orthopedic surgery | Research and Practice in Thrombosis and Haemostasis | 2020 | 39 |
| 47 | Randomized trials of therapeutic heparin for COVID‐19: A meta‐analysis | Research and Practice in Thrombosis and Haemostasis | 2021 | 39 |
| 48 | Platelet preparation for function testing in the laboratory and clinic: Historical and practical aspects | Research and Practice in Thrombosis and Haemostasis | 2019 | 37 |
| 49 | Fibrinolytic therapy for refractory COVID‐19 acute respiratory distress syndrome: Scientific rationale and review | Research and Practice in Thrombosis and Haemostasis | 2020 | 37 |
| 50 | Hematologic concerns in extracorporeal membrane oxygenation | Research and Practice in Thrombosis and Haemostasis | 2020 | 37 |
